Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospit. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Yatharth Hospital & Trauma Care Services Ltd

₹ 614 -0.28%
04 Dec 1:51 p.m.
Company website BSE: 543950 NSE: YATHARTH
About

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Key Points

Hospital Portfolio: [1]
- Total Hospitals: 7 hospitals across North India with 87% of the beds in Metro.

Locations and Beds:[2]
- Greater Noida: 400 beds (112 ICU beds, 66% occupancy).
- Noida: 250 beds (81 ICU beds, 83% occupancy).
- Noida Extension: 450 beds (125 ICU beds, 60% occupancy).
- Jhansi-Orchha: 305 beds (76 ICU beds, 47% occupancy).
- Greater Faridabad: 200 beds (61 ICU beds, ramping up at 28% occupancy).

  • Upcoming Hospitals[3]
    • Model Town, Delhi: ~300 beds.
    • Faridabad (new hospital): ~400 beds.
Website BSE NSE
  • Market Cap ₹ 5,272 Cr.
  • Current Price ₹ 614
  • High / Low ₹ 693 / 360
  • Stock P/E 58.0
  • Book Value ₹ 102
  • Dividend Yield 0.00 %
  • ROCE 21.0 %
  • ROE 16.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 95.9% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.7%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 109 to 133 days.
  • Working capital days have increased from 195 days to 376 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE SmallCap BSE Allcap BSE Healthcare Nifty Total Market Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
83 94 97 97 102 110 102 106 119 113
60 67 69 69 73 79 72 78 86 82
Operating Profit 23 27 28 28 29 31 29 28 33 31
OPM % 28% 28% 29% 29% 28% 28% 29% 26% 28% 27%
0 0 1 0 0 3 5 5 3 2
Interest 2 2 3 2 2 2 0 0 0 0
Depreciation 3 3 3 4 3 3 4 3 4 5
Profit before tax 19 23 22 22 24 30 30 29 31 27
Tax % 29% 30% 12% 30% 35% 30% 30% 10% 26% 26%
13 16 20 15 16 21 21 26 23 20
EPS in Rs 2.02 2.43 3.00 2.34 2.38 2.45 2.46 3.06 2.70 2.38
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
71 78 91 123 165 278 331 394 439
53 59 72 92 120 193 225 275 319
Operating Profit 18 18 20 31 45 85 106 119 120
OPM % 25% 24% 22% 25% 27% 31% 32% 30% 27%
0 0 0 0 1 1 2 14 14
Interest 6 5 6 14 13 13 10 6 1
Depreciation 7 6 8 15 14 13 13 13 16
Profit before tax 5 8 6 3 18 60 86 113 118
Tax % 41% 23% 51% 72% 31% 30% 25% 26%
3 6 3 1 12 42 64 84 91
EPS in Rs 2.22 3.76 1.78 0.49 7.53 6.42 9.79 9.78 10.60
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 34%
3 Years: 34%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 96%
3 Years: 90%
TTM: 27%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 57%
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 26%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 14 16 16 16 16 66 66 86 86
Reserves 24 32 39 40 53 46 111 751 791
85 107 120 113 103 115 117 5 3
10 11 22 32 39 59 33 36 36
Total Liabilities 133 166 197 202 211 286 326 878 916
51 47 146 134 132 122 121 133 142
CWIP 54 80 0 0 0 0 0 0 1
Investments 7 19 28 33 34 47 47 67 67
20 20 22 34 45 117 159 679 705
Total Assets 133 166 197 202 211 286 326 878 916

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
25 19 21 24 26 27 26 16
-45 -39 -36 -8 -4 -18 -9 -167
21 21 11 -20 -23 -7 -6 241
Net Cash Flow 1 2 -4 -4 -1 1 11 89

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 58 44 51 54 70 100 95 133
Inventory Days 47 42 44 37 33
Days Payable 127 106 224 161 154
Cash Conversion Cycle -22 -20 -129 -70 -51 100 95 133
Working Capital Days 20 7 -15 -7 32 80 129 376
ROCE % 9% 7% 10% 18% 37% 37% 21%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
66.33% 66.44% 66.54% 66.54% 66.54%
5.42% 2.59% 3.99% 4.90% 6.28%
8.88% 8.81% 9.30% 9.40% 6.97%
19.37% 22.15% 20.15% 19.16% 20.20%
No. of Shareholders 50,11351,74346,56751,91662,616

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls